Sarepta Therapeutics, Inc. (SRPT) · Insider trading

What Sarepta Therapeutics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$417,410

2 insiders, 0% under a plan

Net, 12 months

−$417,410

bought less sold

Latest filing

2026-09-08

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $1.52M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Wigzell Hans Lennart RudolfDirector	–	$1.31M	1	2024-12-12	22,840
Estepan Ian MichaelChief Operating Officer	–	$294,202	1	2025-12-16	193,300
Nicaise ClaudeDirector	–	$248,203	1	2025-03-12	27,812
Boor Kathryn JeanDirector	–	$205,400	1	2024-12-05	5,880
Mayo StephenDirector	–	$123,208	1	2026-03-12	1,765

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-03-12	Mayo StephenDirector	Sale	7,239	17.02	$123,208	1,765	Form 4
2025-12-16	Estepan Ian MichaelChief Operating Officer	Sale	13,187	22.31	$294,202	193,300	Form 4
2025-03-12	Nicaise ClaudeDirector	Sale	2,491	99.64	$248,203	27,812	Form 4
2024-12-12	Wigzell Hans Lennart RudolfDirector	Sale	10,500	124.84	$1.31M	22,840	Form 4
2024-12-05	Boor Kathryn JeanDirector	Sale	1,636	125.55	$205,400	5,880	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

61 × shares withheld for tax36 × grant or award20 × option exercise1 × gift

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-09-04	Rodino-Klapac LouisePresident, R&D and Tech Ops	Shares withheld for tax F	−21,423	22.22	203,900	Form 4
2026-09-04	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−22,025	22.22	115,519	Form 4
2026-09-04	Estepan Ian MichaelChief Operating Officer	Shares withheld for tax F	−24,799	22.22	177,184	Form 4
2026-09-04	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−13,272	22.22	121,792	Form 4
2026-07-28	Severino MichaelDirector, Chief Executive Officer	Grant or award A	+756,104	–	756,104	Form 4
2026-06-04	Barry RichardDirector	Grant or award A	+16,875	–	2,983,542	Form 4
2026-06-04	Chambers Michael AndrewDirector	Grant or award A	+16,875	–	27,535	Form 4
2026-06-04	Nicaise ClaudeDirector	Grant or award A	+16,875	–	48,407	Form 4
2026-06-04	Connelly Deirdre PDirector	Grant or award A	+16,875	–	22,100	Form 4
2026-06-04	Behrens M KathleenDirector	Grant or award A	+16,875	–	214,357	Form 4
2026-06-04	Wigzell Hans Lennart RudolfDirector	Grant or award A	+16,875	–	42,098	Form 4
2026-06-04	Mayo StephenDirector	Grant or award A	+16,875	–	18,640	Form 4
2026-06-04	Boor Kathryn JeanDirector	Grant or award A	+16,875	–	25,138	Form 4
2026-03-11	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−974	17.03	137,544	Form 4
2026-03-11	Rodino-Klapac LouisePresident, R&D and Tech Ops	Shares withheld for tax F	−948	17.03	225,323	Form 4
2026-03-11	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−256	17.03	135,064	Form 4
2026-03-11	Estepan Ian MichaelChief Operating Officer	Shares withheld for tax F	−1,097	17.03	201,983	Form 4
2026-03-09	Estepan Ian MichaelChief Operating Officer	Shares withheld for tax F	−1,036	16.95	203,663	Form 4
2026-03-09	Estepan Ian MichaelChief Operating Officer	Shares withheld for tax F	−583	16.95	203,080	Form 4
2026-03-09	Rodino-Klapac LouisePresident, R&D and Tech Ops	Shares withheld for tax F	−504	16.95	227,166	Form 4
2026-03-09	Rodino-Klapac LouisePresident, R&D and Tech Ops	Shares withheld for tax F	−895	16.95	226,271	Form 4
2026-03-09	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−484	16.95	138,864	Form 4
2026-03-09	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−346	16.95	138,518	Form 4
2026-03-09	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−162	16.95	135,433	Form 4
2026-03-09	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−113	16.95	135,320	Form 4
2026-03-02	Rodino-Klapac LouisePresident, R&D and Tech Ops	Shares withheld for tax F	−3,718	16.20	228,437	Form 4
2026-03-02	Rodino-Klapac LouisePresident, R&D and Tech Ops	Shares withheld for tax F	−767	16.20	227,670	Form 4
2026-03-02	Estepan Ian MichaelChief Operating Officer	Shares withheld for tax F	−3,301	16.20	205,574	Form 4
2026-03-02	Estepan Ian MichaelChief Operating Officer	Shares withheld for tax F	−875	16.20	204,699	Form 4
2026-03-02	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−450	16.20	135,595	Form 4
2026-03-02	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−408	16.20	139,348	Form 4
2026-03-01	Rodino-Klapac LouisePresident, R&D and Tech Ops	Option exercise M	+8,125	–	232,155	Form 4
2026-03-01	Estepan Ian MichaelChief Operating Officer	Option exercise M	+8,125	–	208,875	Form 4
2026-02-26	Estepan Ian MichaelChief Operating Officer	Option exercise M	+2,069	13.71	195,369	Form 4
2026-02-26	Estepan Ian MichaelChief Operating Officer	Option exercise M	+5,381	13.71	200,750	Form 4
2026-01-29	Nicaise ClaudeDirector	Option exercise M	+10,500	13.71	38,312	Form 4
2026-01-29	Nicaise ClaudeDirector	Shares withheld for tax F	−6,780	21.23	31,532	Form 4
2026-01-27	Behrens M KathleenDirector	Option exercise M	+10,500	13.71	203,976	Form 4
2026-01-27	Behrens M KathleenDirector	Shares withheld for tax F	−6,494	22.17	197,482	Form 4
2025-12-07	Ingram Douglas SDirector, Chief Executive Officer	Grant or award A	+50,000	–	440,307	Form 4
2025-12-07	Ingram Douglas SDirector, Chief Executive Officer	Grant or award A	+50,000	–	490,307	Form 4
2025-12-07	Ingram Douglas SDirector, Chief Executive Officer	Grant or award A	+73,001	–	563,308	Form 4
2025-12-07	Ingram Douglas SDirector, Chief Executive Officer	Grant or award A	+96,541	–	659,849	Form 4
2025-12-07	Ingram Douglas SDirector, Chief Executive Officer	Grant or award A	+269,542	–	929,391	Form 4
2025-12-01	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−80	20.96	136,123	Form 4
2025-12-01	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−78	20.96	136,045	Form 4
2025-11-28	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−229	21.12	139,756	Form 4
2025-11-17	Rodino-Klapac LouisePresident, R&D and Tech Ops	Shares withheld for tax F	−4,582	18.42	224,030	Form 4
2025-09-03	Rothfuss CristinEVP, General Counsel	Grant or award A	+93,875	–	114,985	Form 4
2025-09-03	Rothfuss CristinEVP, General Counsel	Grant or award A	+25,000	–	139,985	Form 4
2025-09-03	Estepan Ian MichaelChief Operating Officer	Grant or award A	+93,875	–	156,487	Form 4
2025-09-03	Estepan Ian MichaelChief Operating Officer	Grant or award A	+50,000	–	206,487	Form 4
2025-09-03	Wong Ryan Ho-YanChief Financial Officer	Grant or award A	+93,875	–	111,203	Form 4
2025-09-03	Wong Ryan Ho-YanChief Financial Officer	Grant or award A	+25,000	–	136,203	Form 4
2025-09-03	Rodino-Klapac LouisePresident, R&D and Tech Ops	Grant or award A	+93,875	–	178,612	Form 4
2025-09-03	Rodino-Klapac LouisePresident, R&D and Tech Ops	Grant or award A	+50,000	–	228,612	Form 4
2025-07-31	Wong Ryan Ho-YanChief Financial Officer	Shares withheld for tax F	−327	16.42	17,328	Form 4
2025-05-16	Barry RichardDirector	Option exercise M	+12,350	32.63	2,966,667	Form 4
2025-05-13	Barry RichardDirector	Option exercise M	+9,746	25.18	2,943,817	Form 4
2025-05-13	Barry RichardDirector	Option exercise M	+10,500	13.71	2,954,317	Form 4
2025-03-12	Nicaise ClaudeDirector	Option exercise M	+9,746	25.18	30,303	Form 4
2025-03-10	Behrens M KathleenDirector	Grant or award A	+2,383	–	193,476	Form 4
2025-03-10	Barry RichardDirector	Grant or award A	+2,383	–	2,934,071	Form 4
2025-03-10	Murray DallanChief Customer Officer	Shares withheld for tax F	−996	100.13	32,663	Form 4
2025-03-10	Murray DallanChief Customer Officer	Shares withheld for tax F	−2,737	100.13	29,926	Form 4
2025-03-10	Murray DallanChief Customer Officer	Grant or award A	+8,276	–	38,202	Form 4
2025-03-10	Estepan Ian MichaelChief Financial Officer	Shares withheld for tax F	−1,051	100.13	57,226	Form 4
2025-03-10	Estepan Ian MichaelChief Financial Officer	Shares withheld for tax F	−2,890	100.13	54,336	Form 4
2025-03-10	Estepan Ian MichaelChief Financial Officer	Grant or award A	+8,276	–	62,612	Form 4
2025-03-10	Nicaise ClaudeDirector	Grant or award A	+2,383	–	20,557	Form 4
2025-03-10	Rodino-Klapac LouiseHead of R&D, CSO	Shares withheld for tax F	−924	100.13	78,894	Form 4
2025-03-10	Rodino-Klapac LouiseHead of R&D, CSO	Shares withheld for tax F	−2,539	100.13	76,355	Form 4
2025-03-10	Rodino-Klapac LouiseHead of R&D, CSO	Grant or award A	+8,276	–	84,631	Form 4
2025-03-10	Arif BilalChief Tech Ops Officer	Shares withheld for tax F	−523	100.13	24,224	Form 4
2025-03-10	Arif BilalChief Tech Ops Officer	Grant or award A	+8,276	–	32,500	Form 4
2025-03-10	Mayo StephenDirector	Grant or award A	+2,383	–	9,004	Form 4
2025-03-10	Wigzell Hans Lennart RudolfDirector	Grant or award A	+2,383	–	25,223	Form 4
2025-03-10	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−491	100.13	12,834	Form 4
2025-03-10	Rothfuss CristinEVP, General Counsel	Grant or award A	+8,276	–	21,110	Form 4
2025-03-10	Chambers Michael AndrewDirector	Grant or award A	+2,383	–	10,660	Form 4
2025-03-10	Boor Kathryn JeanDirector	Grant or award A	+2,383	–	8,263	Form 4
2025-03-10	Connelly Deirdre PDirector	Grant or award A	+2,383	–	5,225	Form 4
2025-03-07	Murray DallanChief Customer Officer	Option exercise M	+5,500	–	33,659	Form 4
2025-03-07	Estepan Ian MichaelChief Financial Officer	Option exercise M	+5,500	–	58,277	Form 4
2025-03-07	Rodino-Klapac LouiseHead of R&D, CSO	Option exercise M	+5,500	–	79,818	Form 4
2025-03-07	Arif BilalChief Tech Ops Officer	Shares withheld for tax F	−508	103.70	33,274	Form 4
2025-03-07	Arif BilalChief Tech Ops Officer	Shares withheld for tax F	−8,527	103.70	24,747	Form 4
2025-03-07	Murray DallanChief Customer Officer	Shares withheld for tax F	−549	103.70	36,772	Form 4
2025-03-07	Murray DallanChief Customer Officer	Shares withheld for tax F	−8,613	103.70	28,159	Form 4
2025-03-07	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−1,131	103.70	12,194	Form 4
2025-03-07	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−347	103.70	11,847	Form 4
2025-03-07	Rodino-Klapac LouiseHead of R&D, CSO	Shares withheld for tax F	−514	103.70	82,308	Form 4
2025-03-07	Rodino-Klapac LouiseHead of R&D, CSO	Shares withheld for tax F	−7,990	103.70	74,318	Form 4
2025-03-07	Estepan Ian MichaelChief Financial Officer	Shares withheld for tax F	−585	103.70	61,871	Form 4
2025-03-07	Estepan Ian MichaelChief Financial Officer	Shares withheld for tax F	−9,094	103.70	52,777	Form 4
2025-03-06	Arif BilalChief Tech Ops Officer	Option exercise M	+17,500	–	33,782	Form 4
2025-03-06	Murray DallanChief Customer Officer	Option exercise M	+17,500	–	37,321	Form 4
2025-03-06	Rodino-Klapac LouiseHead of R&D, CSO	Option exercise M	+17,500	–	82,822	Form 4
2025-03-06	Estepan Ian MichaelChief Financial Officer	Option exercise M	+17,500	–	62,456	Form 4
2025-03-04	Rodino-Klapac LouiseHead of R&D, CSO	Shares withheld for tax F	−1,704	101.34	65,322	Form 4
2025-03-04	Estepan Ian MichaelChief Financial Officer	Shares withheld for tax F	−1,370	101.34	44,956	Form 4
2025-03-04	Murray DallanChief Customer Officer	Shares withheld for tax F	−1,685	101.34	19,821	Form 4
2025-03-04	Arif BilalChief Tech Ops Officer	Shares withheld for tax F	−281	101.34	16,515	Form 4
2025-03-04	Arif BilalChief Tech Ops Officer	Shares withheld for tax F	−233	101.34	16,282	Form 4
2025-03-04	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−288	101.34	13,037	Form 4
2025-03-04	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−296	101.34	13,325	Form 4
2025-03-03	Rothfuss CristinEVP, General Counsel	Shares withheld for tax F	−391	103.77	13,621	Form 4
2025-03-03	Rodino-Klapac LouiseHead of R&D, CSO	Shares withheld for tax F	−715	103.77	67,026	Form 4
2025-03-03	Estepan Ian MichaelChief Financial Officer	Shares withheld for tax F	−557	103.77	46,326	Form 4
2025-03-03	Arif BilalChief Tech Ops Officer	Shares withheld for tax F	−719	103.77	16,796	Form 4
2025-03-03	Murray DallanChief Customer Officer	Shares withheld for tax F	−711	103.77	21,506	Form 4
2025-01-29	Estepan Ian MichaelChief Financial Officer	Option exercise M	+14,267	12.00	47,963	Form 4
2025-01-29	Estepan Ian MichaelChief Financial Officer	Option exercise M	+1,533	12.00	49,496	Form 4
2025-01-29	Estepan Ian MichaelChief Financial Officer	Shares withheld for tax F	−2,613	117.51	46,883	Form 4
2024-12-27	Estepan Ian MichaelChief Financial Officer	Gift G	−250	–	33,696	Form 4
2024-12-12	Wigzell Hans Lennart RudolfDirector	Option exercise M	+10,500	13.71	33,340	Form 4
2024-11-26	Rothfuss CristinEVP, General Counsel	Grant or award A	+2,000	–	13,817	Form 4
2024-11-18	Rodino-Klapac LouiseHead of R&D, CSO	Shares withheld for tax F	−4,558	102.89	67,630	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Sarepta Therapeutics's scores and multiples ›